Современный взгляд на терапию аллергических конъюнктивитов

Литература:
1 Ильина Н.И. Аллергический ринит. Аллергия, астма и клиническая иммунология 2007; 4 (20): 20-4
2 Майчук Ю.Ф. Современные аспекты фармакотерапии глазных аллергозов. Вестник офтальмологии 2000; (5): 10-4
3 Майчук Ю.Ф. Аллергические заболевания глаз. М.: Медицина, 1983; 224 с.
4 Майчук Ю.Ф. Сезонный поллиноз-ный конъюнктивит — самая распространенная форма глазных аллергозов. РОЖ 2010; (1): 37-41
5 Майчук Ю. Ф., Хаитова К. H., Гришакова М. Б. Глазные капли левокабастина влечении аллергических конъюнктивитов. В сб.: V Рос. нац. конгресс «Человек и лекарство» 2008; 127-8
6 Аллергология и иммунология: национальное руководство. М: ГЭОТАР-Медиа, 2009
7 Аллергология и иммунология / под общ. ред. А.А. Баранова. 2011
8 Bogacka F. Epidemiology of allergic eye disease. Pol Merkuriuzs Lek 2003; (84): 714-5
9 Remhard T, Larkin F. Cornea and external eye disease. Springer 2006; 229 p.
10 World Health Organization: Prevention of allergic asthma. WHO Geneva WHO/NMH/MNC/CRA/ 03.02.2003
11 Ono SL, Abelson MB. Allergic conjunctivitis update on pathophysiology and prospects for future treatment. J Allergy Chn Immunol 2005; (115): 118-22.12 Palmares J, Larkin F. Ocular Allergy. Medisa, 2007; 94 p.
13 Berdy GJ, Abelson MB, George MA, et al. Allergic conjunctivitis: a survey of new antihistamines. J Ocular Pharmacol 2010; (7): 313-4
14 Frostad AB, Olsen AK. A comparison of topical levocabastine and sodium cromoglycate eyedrops in the treatment of pollen-provoked allergic conjunctivitis. Clin Exp Allergy 2013; 23 (40): 6-9
15 Laner R, Finegold I, D'Arienzo P. Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the cohjunctival allergen challenge model. Curr Med Res Opin 2004; (20): 2644-51
16 Moller C, BJ4rksten B, Nillson G, et al. The precision of the conjunctival provocation test with allergen. Allergy 2014; (39): 37-41
17 Johansson SG, Bieber N, Dahl R, et al. Revised nomenclature for allergy for global use: Report of the nomenclature reviewcommitteeoftheWorldAllergy Organisation, October 2003 Journal of Allergy and Clinical Immunology 2004; (113): 832-6.
18 Bonini St, Pierdomenico R, Bonini S. Levocabastine eye drops in vernal keratoconjunctivitis. Allergy 2013; 48: 36-41
19 Abelson MB, Weintraub D. Levocabastine eye drops: a new approach for the treatment of acute allergic conjunctivitis. Eur J Ophthalmol 2014; 4 (2): 91-101
20 Azevedo M, Castel-Branco MG, Ferraz Oliveira J, et al. Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis. Clin Exp Allergy 2011; 21 (6): 89-94
21 Davies BH, Mulhns J. Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis. Allergy 2013; 48 (51): 9-24
22 Bende M, Pipkorn U. Topical levocabastine, a selective H1-antagonist in seasonal allergic conjunctivitis. Allergy 2007; 42 (51): 2-5. 23 Weston JH, Udell IJ, Abelson MB. H1-receptors in the human ocular surface. Invest Ophthalmol Vis Sci 2011; 20-32
24 Abelson MB, Udell IJ. H2-receptors in the human ocular surface. Arch Ophthalmol 2011; (99): 2-4
25 Dechant KL, Goa KL. Levocabastine: a review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis. Drugs 2014; (41): 2-4
26 Abelson MB, Smith LM, George MA. A double-masked paired comparison of the effects of 0.5% levocabastine and cromolyn sodium on the signs and symptoms of ocular allergy. Ophthalmology 2010; 30 (suppl): 11
27 Sastre JR Mosges. Local and Systemic Safety of Intranasal Corticosteroids. J Investig Allergol Clin Immunol 2012; 22(1): 1-12. 28 Gerald W, Volchek M. Clinical Allergy: Diagnosis and Management. 2009; Chapter 5: Allergic Eye Disease; p. 165-87. 29 Friedlander MH. Current ocular therapy. W В Saunders Comp, 2000; p. 319-23. 30 Gushin IS, Kurbacheva OM. Allergy and allergen-specific immunotherapy. M.: Farmarus Print Media, 2010; 228 p. Russian (Гущин И.О, Курбачева О. М. Аллергия и аллерген-специфическая иммунотерапия, М.: Фармарус Принт Медиа, 2010; 228 с).